Skip to main content

Table 3 The serum of miR-10b-3p expression status and clinicopathological characteristics of patients with ESCC

From: Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)

Characteristics miR-10b-3p expression status
Low (n = 46) High (n = 46) P
Gender
 Male 33 (47.8%) 36 (52.2%) 0.470
 Female 13 (56.5%) 10 (43.5%)
Age
 <60 19 (44.2%) 24 (55.8%) 0.296
  ≥ 60 27 (55.1%) 22 (44.9%)
Tumor size
 < 5 cm 31 (51.7%) 29 (77.5%) 0.662
  ≥ 5 cm 15 (22.5%) 17 (22.5%)
Tumor stage
 T1+ T2 18 (60.0%) 12 (40.0%) 0.182
 T3+ T4 28 (45.2%) 34 (54.8%)
Histological grade
 Well/moderate 36 (53.7%) 31 (46.3%) 0.241
 Poor/NS 10 (40.0%) 15 (60.0%)
Lymph node metastasis
 Negative 26 (65.0%) 14 (35.0%) 0.012
 Positive 20 (38.5%) 32 (61.5%)
Clinical stages
 I + II 37 (69.8%) 16 (30.2%) 0.000
 III + IV 9 (23.1%) 30 (76.9%)